Experimental study of combined treatment with tacrolimus and donor splenocytes via the portal vein in small bowel transplantation

スポンサーリンク

概要

• 論文の詳細を見る

• We previously reported that the combined treatment of perioperative administration of donor splenocytes via the recipient's portal vein (DSPV) and a short-course Tacrolimus significantly prolonged the survival of fully allogenic grafts in rat small bowel transplantation (SBTX). In the present study we examined whether this effect depended on the quantity of the administered alloantigens in DSPV. In addition, we examined the expression of the surface antigen on T cells of the splenocytes and the induced toleragenic factor, according to the tolerant recipients which in our previous report had shown the prolongation of allogenic transplant small bowel graft survival by the combined treatment of DSPV (1×108 donor splenocytes) and a short-course Tacrolimus. Donor splenocytes were prepared from Brown-Norway (BN (RT1n)) rat spleens for Lewis (LEW (RT1l)) recipients. The recipients (n=10), treated with a short course of Tacrolimus (0.5mg/kg, 0 to 3 days postoperatively) only showed graft rejection with an average of 6.3±1.0 days postoperatively. However, the combined treatment, consisting of DSPV of 1×108 donor splenocytes and a short course Tacrolimus significantly prolonged graft survival to 12.7±2.1 days (n=12, P<0.01). DSPV of less than 1×108 donor splenocytes (5×107 cells and 2.5×107) could not prolong the graft or animal survival under a short-course Tacrolimus treatment. In the tolerant recipients, the CD4 and CD8 percentages of splenocytes were not significantly different from those of control rats or recipients that were treated with short-course Tacrolimus alone. Neverthless, the percentage of Tcr-αβ+ cells expressing IL-2 receptor (R) was significantly lower than in either control rats or the recipients with short-course Tacrolimus. In the suppression assay to one-way mixed lymphocyte response, a toleragenic factor was suggested to the present in the serum of the tolerant recipients. In the present study, it was suggested that the effects of the combined treatment of DSPV and short-course Tacrolimus for the prolongation of graft survival in the rat allogenic SBTX should depended on the quantity of the antigens administered into the portal vein. The beneficial effects of this treatment were reflected in the suppression of IL-2R on the recipient's splenocytes, and tolerogenic factor(s) might subsequently be induced in the tolerant recipient's serum.

• 徳島大学の論文

著者

• Tashiro Seiki

  徳島大学医学部

• Ishikawa Masashi

  First Department Of Surgery University Of Tokushima School Of Medicine

• Ishikawa Masashi

  徳島大学医学部

• Ishikawa Masashi

  First Department Of Surgery The University Of Tokushima School Of Medicine

• Miyauchi Takayuki

  国立高知病院

• Miyauchi Takayuki

  徳島大学医学部

• Tashiro Seiji

  徳島大学医学部

関連論文

• Can the Liver with Gilbert's syndrome be used as graft of living-related liver transplantation?
• Hepatocellular carcinoma effectively treated by intravenous infusion of cisplatin
• The effect continuous arterial infusion of Gabexate Mesilate (FOY-007) on experimental acute pancreatitis
• Intraoperative microwave coagulation therapy for large hepatic tumors
• Current status of surgical treatment for hepatocellular carcinoma
• A case of adenomatous hyperplasia in the liver with chronic hepatitis C that transformed into hepatocellular carcinoma
• Evaluation of the Acetaminophen Absorption Test for Early Detection of Orthotopic Small Bowel Transplant Rejection
• Donor-specific tolerance induced by simultaneous allogeneic islet transplantation with CD4^+CD25^+T-cells into hepatic parenchyma in mice
• A new method for determining cellular atp content in hepatocytes
• Successful resection of cholangiocellular carcinoma with tumor thrombus in the main trunk of the portal vein
• Functional assessment of liver for extended hepatic resection in patients with obstructive jaundice
• Hepatocellular carcinoma with extension into the right atrium : report of a successful liver resection by hepatic vascular exclusion using cardiopulmonary bypass
• Effect of intermittent liver ischemia on outcome in patients with hepatocellular carcinoma on liver cirrhosis
• Inhibitory effect of FK506 and Cyclosporine A on the growth and invasion of human liver cancer cells
• Clinical study of strangulation obstruction of the small bowel
• Experimental study of combined treatment with tacrolimus and donor splenocytes via the portal vein in small bowel transplantation
• Giant gastrointestinal stromal tumor,associated with esophageal hiatus hernia
• Rectus sheath hematoma in an elderly woman under anti-coagulant therapy
• A case of adenomatous hyperplasia in the liver with chronic hepatitis C that transformed into hepatocellular carcinoma

もっと見る 閉じる

スポンサーリンク